Skip to content
Donate

← All news

Tackling Antimicrobial Resistance: The $100 Trillion Threat and the Imperative for Global Action

7 November 2026

Jump to

As World AMR Awareness Week (WAAW) 2026 approaches, the global healthcare community and capital markets face a critical juncture. Antimicrobial Resistance (AMR) is projected to cost the global economy up to $100 trillion by 2050—a systemic risk on par with climate change and a leading cause of mortality worldwide.

Without effective antimicrobials, modern clinical care, global health security, and community resilience face unprecedented threats. Addressing AMR requires an integrated “One Health” approach bridging clinical stewardship, rapid diagnostic innovation, community prevention, and blended finance mechanisms.

Expert Insights & Quotes

“Antimicrobial resistance is an immediate, accelerating global threat. While the pharmaceutical sector focuses on drug discovery, the international consensus is clear: AMR is fundamentally an implementation and behavioral crisis driven by frontline clinical prescribing habits, diagnostic delays, and public patient compliance. If we don’t act now, the human and economic toll will be catastrophic.” — Dr. Ron Daniels BEM, Founder & CEO of the UK Sepsis Trust, Vice-President of the Global Sepsis Alliance

“By aligning clinical excellence, behavioral architecture, and sophisticated finance, we can turn a global threat into a sovereign innovation engine. Tackling AMR requires sustained cross-sector action—from frontline clinical checklists to community-led social prescribing and preventative healthcare models.” — Gareth Presch, Founder & CEO, World Health Innovation Summit (WHIS) CIC

Featured Video: World Health Innovation Summit 2024 Online Panel Discussion To explore the macroeconomic, clinical, and preventative dimensions of this threat, rewatch our session from the WHIS 2024 Emerging Diseases Panel:

🌍 Tackling AMR: The Economic and Health Imperative🚨 🗓 Date: 29th November 2024 🕦 Time: 11:30 AM – 12:15 PM BST 🎥 Location: Online (WHIS 2024 Emerging Diseases Panel) Antimicrobial Resistance (AMR) poses one of the greatest threats to global health and the economy. Join us for a critical discussion on the challenges and opportunities in combating AMR and emerging diseases of concern. ✨ Our Esteemed Panelists:

  • 💊 Dr. Ron Daniels – AMR Specialist & Sepsis Expert
  • 🌱 Abigail Herron – Aviva Investors, Sustainable Finance Advocate
  • 🧬 Dr. Tom Ashfield – Innovator in Precision Health

Key Takeaways & Session Highlights:

  • ✅ Economic Risk: The projected $100 trillion economic loss by 2050 if AMR goes unchecked.
  • ✅ Cross-Sector Ripple Effects: Impact across industries, from agriculture and healthcare delivery to insurance and capital markets.
  • ✅ Investing in Solutions: Capital allocation into infection prevention, precision medicine, rapid diagnostics, and sustainable practices.
  • ✅ Innovation & Collaboration: The vital role of multi-stakeholder collaboration in mitigating this crisis.

💡 AMR is a wake-up call for action and innovation. Learn how integrated solutions protect lives, economies, and our shared future. 🌟

🔗 Watch the Panel Recording & Access Resources: WHIS Campaign

Join the Movement for WAAW 2026 Ahead of World AMR Awareness Week (18–24 Nov 2026), World Health Innovation Summit invites clinical leaders, policymakers, corporate partners, and advocates to align around actionable stewardship and community prevention models.

Older story → The World Health Service DAF: Connecting Philanthropic Ambition with Global Health Prevention